Chiao-Shih Tseng, Shih-Ming Chen, Shu-Chen Chien, Kuang-Yang Hsu
Index: Adv. Pharmacol. Sci. 2011 , 204501, (2011)
Full Text: HTML
The characteristics of aristolochic acid nephropathy (AAN) are interstitial fibrosis and atrophy of the proximal tubules, but with no change in glomeruli. To investigate the effects of AA on renal functions and the pharmacokinetics (PKs) of p-aminohippuric acid (PAH) and inulin, New Zealand white rabbits were used in this study. The plasma concentrations of PAH and inulin were determined by validated HPLC methods. After a single intravenous administration of 0.5 mg/kg aristolochic acid sodium (AANa), rabbits exhibited mild to moderate nephrotoxicity on the 7th day. Significant tubulointerstitial damage to kidney specimens was found, but there were no remarkable glomerular changes. Clearance rates of PAH and inulin both significantly decreased in AANa-treated rabbits. In addition, there was a significant correlation among the degree of tubulointerstitial changes and PK parameters of PAH after AANa administration, but no correlation was noted with the PKs of inulin. With mild to moderate AAN in rabbits, the renal plasma flow significantly decreased by 55%, and the glomerular filtration rate also significantly decreased by 85%. In conclusion, major renal lesions were found on proximal tubules after AANa administration. The PKs of PAH and inulin significantly changed, and kidney functions, including the RPF and GFR, were reduced.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Sodium [(4-aminobenzoyl)amino]acetate
CAS:94-16-6 |
C9H9N2NaO3 |
Balanced Hydroxyethylstarch (HES 130/0.4) Impairs Kidney Fun...
2015-01-01 [PLoS ONE 10 , e0137247, (2015)] |
Flavonoid conjugates interact with organic anion transporter...
2011-04-01 [Biochem. Pharmacol. 81 , 942-949, (2011)] |
Molecular evidence for an involvement of organic anion trans...
2009-10-01 [Toxicology 264 , 74-79, (2009)] |
Molecular and functional identification of organic anion tra...
2012-06-01 [J. Vet. Pharmacol. Ther. 35(3) , 209-15, (2011)] |
Determining the mechanisms underlying augmented renal drug c...
2014-01-01 [Crit. Care 18 , 657, (2015)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved